Drug Approval | April 08, 2026
Lupin wins USFDA nod for generic Dapagliflozin tablets
Approval for 5 mg and 10 mg strengths, bioequivalent to Farxiga®, strengthens Lupin’s anti-diabetic portfolio in US market
Approval for 5 mg and 10 mg strengths, bioequivalent to Farxiga®, strengthens Lupin’s anti-diabetic portfolio in US market
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide
TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
Opioid dependence remains a major driver of death and disease worldwide
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
Subscribe To Our Newsletter & Stay Updated
